IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $130,000 | -9.7% | 10,245 | -5.4% | 0.00% | 0.0% |
| Q4 2016 | $144,000 | -41.9% | 10,835 | +3.3% | 0.00% | -50.0% |
| Q3 2016 | $248,000 | +2.5% | 10,485 | +85.5% | 0.00% | 0.0% |
| Q4 2015 | $242,000 | +7.1% | 5,652 | -11.9% | 0.00% | 0.0% |
| Q3 2015 | $226,000 | -51.3% | 6,412 | -36.5% | 0.00% | -50.0% |
| Q2 2015 | $464,000 | -40.8% | 10,100 | -39.6% | 0.00% | -42.9% |
| Q1 2015 | $784,000 | +48.5% | 16,730 | +0.4% | 0.01% | +40.0% |
| Q4 2014 | $528,000 | +28.8% | 16,670 | -3.6% | 0.01% | 0.0% |
| Q3 2014 | $410,000 | -22.5% | 17,295 | -1.9% | 0.01% | 0.0% |
| Q2 2014 | $529,000 | -21.9% | 17,635 | -31.2% | 0.01% | -28.6% |
| Q1 2014 | $677,000 | +122.0% | 25,630 | +110.9% | 0.01% | +133.3% |
| Q4 2013 | $305,000 | +22.5% | 12,150 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $249,000 | -15.0% | 12,150 | -17.2% | 0.00% | -25.0% |
| Q2 2013 | $293,000 | – | 14,680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 560,400 | $9,022,000 | 3.93% |
| NORTH TIDE CAPITAL, LLC | 1,000,000 | $16,100,000 | 3.58% |
| Sivik Global Healthcare LLC | 250,000 | $4,025,000 | 1.47% |
| MAVERICK CAPITAL LTD | 7,159,336 | $115,265,000 | 1.44% |
| SECTOR GAMMA AS | 589,311 | $9,488,000 | 1.38% |
| BRIDGER MANAGEMENT, LLC | 1,341,143 | $21,592,000 | 1.23% |
| Eos Focused Equity Management, L.P. | 48,714 | $784,000 | 0.89% |
| Bridge City Capital, LLC | 47,194 | $760,000 | 0.64% |
| Fosun International Ltd | 300,000 | $4,830,000 | 0.60% |
| Century Capital Management, LLC | 203,138 | $3,271,000 | 0.56% |